🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
14.27
+0.45 (3.26%)
Nov 18, 2026, 12:11 PM EST - Market open

ADARx Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, ADARx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $34.25. The average 1-year stock price forecast is 140.01% higher than the current stock price, while the lowest is $32 (+124.25%) and the highest is $38 (+166.29%).

Price Target: $34.25 (+140.01%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$32$34.25$33.5$38
Change+124.25%+140.01%+134.76%+166.29%

Analyst Ratings

The average analyst rating for ADARx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingOct '26Nov '26
Strong Buy33
Buy22
Hold00
Sell00
Strong Sell00
Total55

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Maintains
$32
BuyMaintains$32+124.25%Nov 13, 2026
J.P. Morgan
J.P. Morgan
Buy
Initiates
$38
BuyInitiates$38+166.29%Oct 20, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aOct 20, 2026
UBS
UBS
Buy
Initiates
$35
BuyInitiates$35+145.27%Oct 20, 2026

Financial Forecast

Revenue This Year
6.21M
from 3.45M
Increased by 80.10%
Revenue Next Year
39.87M
from 6.21M
Increased by 541.88%
EPS This Year
-2.03
EPS Next Year
-1.45
from -2.03
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-3.45M6.21M
Revenue Growth
--80.10%
Operating Income
-58.23M-88.37M-129.56M
Net Income
-46.36M-73.09M-118.03M
EPS
---2.03
Free Cash Flow
---122.00M
No. Analysts
--2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High7.3M
Avg6.2M
Low5.1M

Revenue Growth

Revenue Growth202620272028
High
112.2%
Avg
80.1%
Low
48.0%

EPS Forecast

EPS202620272028
High-1.61
Avg-2.03
Low-2.58

EPS Growth

EPS Growth20272028
High-
Avg-
Low-